LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis
NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to LNTH. LNTH was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making LNTH a very profitable company, without any liquidiy or solvency issues. LNTH may be a bit undervalued, certainly considering the very reasonable score on growth This makes LNTH very considerable for value and quality investing!
1. Profitability
1.1 Basic Checks
In the past year LNTH was profitable.
In the past year LNTH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
In the past 5 years LNTH always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 12.37%, LNTH belongs to the best of the industry, outperforming 94.18% of the companies in the same industry.
LNTH has a Return On Equity of 21.85%. This is amongst the best in the industry. LNTH outperforms 94.18% of its industry peers.
LNTH has a better Return On Invested Capital (18.93%) than 97.35% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LNTH is significantly above the industry average of 7.87%.
The 3 year average ROIC (16.25%) for LNTH is below the current ROIC(18.93%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROIC | 18.93% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 16.55%, LNTH belongs to the best of the industry, outperforming 93.12% of the companies in the same industry.
LNTH's Profit Margin has improved in the last couple of years.
The Operating Margin of LNTH (29.30%) is better than 97.88% of its industry peers.
LNTH's Operating Margin has improved in the last couple of years.
The Gross Margin of LNTH (64.04%) is better than 65.08% of its industry peers.
LNTH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% |
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
2. Health
2.1 Basic Checks
LNTH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, LNTH has about the same amount of shares outstanding.
The number of shares outstanding for LNTH has been increased compared to 5 years ago.
The debt/assets ratio for LNTH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.96 indicates that LNTH is not in any danger for bankruptcy at the moment.
The Altman-Z score of LNTH (5.96) is better than 79.89% of its industry peers.
LNTH has a debt to FCF ratio of 1.20. This is a very positive value and a sign of high solvency as it would only need 1.20 years to pay back of all of its debts.
The Debt to FCF ratio of LNTH (1.20) is better than 91.01% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that LNTH is not too dependend on debt financing.
LNTH has a Debt to Equity ratio of 0.49. This is comparable to the rest of the industry: LNTH outperforms 41.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Altman-Z | 5.96 |
ROIC/WACC2.22
WACC8.51%
2.3 Liquidity
LNTH has a Current Ratio of 5.74. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.74, LNTH belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
LNTH has a Quick Ratio of 5.46. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
LNTH has a Quick ratio of 5.46. This is amongst the best in the industry. LNTH outperforms 82.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 |
3. Growth
3.1 Past
LNTH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.64%.
LNTH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.10% yearly.
Looking at the last year, LNTH shows a quite strong growth in Revenue. The Revenue has grown by 12.53% in the last year.
Measured over the past years, LNTH shows a very strong growth in Revenue. The Revenue has been growing by 34.59% on average per year.
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
3.2 Future
Based on estimates for the next years, LNTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.23% on average per year.
Based on estimates for the next years, LNTH will show a quite strong growth in Revenue. The Revenue will grow by 8.86% on average per year.
EPS Next Y0.63%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y9.23%
Revenue Next Year3.55%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y8.86%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.26 indicates a reasonable valuation of LNTH.
Based on the Price/Earnings ratio, LNTH is valued cheaper than 93.65% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.91. LNTH is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.86, the valuation of LNTH can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 92.59% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.85, LNTH is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.26 | ||
| Fwd PE | 9.86 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LNTH is valued cheaply inside the industry as 91.53% of the companies are valued more expensively.
94.71% of the companies in the same industry are more expensive than LNTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.79 | ||
| EV/EBITDA | 9.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LNTH does not grow enough to justify the current Price/Earnings ratio.
LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)17.84
PEG (5Y)0.27
EPS Next 2Y5.56%
EPS Next 3Y9.03%
5. Dividend
5.1 Amount
No dividends for LNTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:LNTH (5/23/2025, 11:50:05 AM)
74.52
-0.23 (-0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners110.89%
Inst Owner Change6.21%
Ins Owners1.47%
Ins Owner Change6.9%
Market Cap5.10B
Analysts82.11
Price Target137.62 (84.68%)
Short Float %10.33%
Short Ratio6.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.03%
Min EPS beat(2)-9.67%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)-1.14%
Min EPS beat(4)-9.67%
Max EPS beat(4)7.07%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)10
Avg EPS beat(12)11.67%
EPS beat(16)14
Avg EPS beat(16)27.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.72%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.13%
Revenue beat(4)2
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)2.13%
Revenue beat(8)5
Avg Revenue beat(8)1%
Revenue beat(12)9
Avg Revenue beat(12)2.39%
Revenue beat(16)13
Avg Revenue beat(16)4.62%
PT rev (1m)0.4%
PT rev (3m)0.17%
EPS NQ rev (1m)-2.05%
EPS NQ rev (3m)2.34%
EPS NY rev (1m)-4.92%
EPS NY rev (3m)-4.01%
Revenue NQ rev (1m)-1.36%
Revenue NQ rev (3m)-1.69%
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.26 | ||
| Fwd PE | 9.86 | ||
| P/S | 3.32 | ||
| P/FCF | 10.79 | ||
| P/OCF | 9.72 | ||
| P/B | 4.38 | ||
| P/tB | 5.38 | ||
| EV/EBITDA | 9.25 |
EPS(TTM)6.62
EY8.88%
EPS(NY)7.55
Fwd EY10.14%
FCF(TTM)6.91
FCFY9.27%
OCF(TTM)7.67
OCFY10.29%
SpS22.44
BVpS17
TBVpS13.86
PEG (NY)17.84
PEG (5Y)0.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.37% | ||
| ROE | 21.85% | ||
| ROCE | 24.91% | ||
| ROIC | 18.93% | ||
| ROICexc | 39.39% | ||
| ROICexgc | 52.34% | ||
| OM | 29.3% | ||
| PM (TTM) | 16.55% | ||
| GM | 64.04% | ||
| FCFM | 30.78% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score8
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 1.2 | ||
| Debt/EBITDA | 1.1 | ||
| Cap/Depr | 82.91% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.34% | ||
| Profit Quality | 185.99% | ||
| Current Ratio | 5.74 | ||
| Quick Ratio | 5.46 | ||
| Altman-Z | 5.96 |
F-Score8
WACC8.51%
ROIC/WACC2.22
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.64%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.47%
EPS Next Y0.63%
EPS Next 2Y5.56%
EPS Next 3Y9.03%
EPS Next 5Y9.23%
Revenue 1Y (TTM)12.53%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%0.75%
Revenue Next Year3.55%
Revenue Next 2Y6.41%
Revenue Next 3Y8.41%
Revenue Next 5Y8.86%
EBIT growth 1Y-5.08%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year12.63%
EBIT Next 3Y13.72%
EBIT Next 5YN/A
FCF growth 1Y32.98%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y38.18%
OCF growth 3Y116.21%
OCF growth 5Y46.62%